1. Academic Validation
  2. Discovery of potent chromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK) using a small-molecule library approach

Discovery of potent chromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK) using a small-molecule library approach

  • J Med Chem. 2005 Dec 1;48(24):7829-46. doi: 10.1021/jm050444b.
Ian R Hardcastle 1 Xiaoling Cockcroft Nicola J Curtin Marine Desage El-Murr Justin J J Leahy Martin Stockley Bernard T Golding Laurent Rigoreau Caroline Richardson Graeme C M Smith Roger J Griffin
Affiliations

Affiliation

  • 1 Northern Institute for Cancer Research, School of Natural Sciences--Chemistry, Bedson Building, Newcastle upon Tyne NE1 7RU, UK. I.R.Hardcastle@ncl.ac.uk
Abstract

Structure-activity relationships for inhibition of DNA-dependent protein kinase (DNA-PK) have been defined for substituted chromen-4-ones. For the 2-amino-substituted benzo[h]chromen-4-ones, a morpholine substituent at this position was essential for activity. Small libraries of 6- and 7-alkoxy-substituted chromen-4-ones showed that a number of 7-alkoxy-substituted chromenones displayed improved activity. Focused libraries incorporating 6-, 7-, and 8-aryl and heteroaryl substituents were prepared. In these cases, 6- and 7-substitution was disfavored, whereas 8-substitution was largely tolerated. Surprisingly, two compounds, 2-N-morpholino-8-dibenzofuranyl-chromen-4-one (NU7427, 32{38}) and the 2-N-morpholino-8-dibenzothiophenyl-chromen-4-one (NU7441, 32{26}) were excellent inhibitors (IC50 vs DNA-PK = 40 and 13 nM, respectively). The ring-saturated analogue 2-N-morpholino-8-(6',7',8',9'-tetrahydrodibenzothiophene)chromen-4-one, 36, retained potent activity (IC50 vs DNA-PK = 23 nM). The dibenzothiophene 32{38} sensitized HeLa cells to ionizing radiation in vitro, with dose modification factors of 2.5 at 10% survival being observed at 0.5 microM. The cytotoxicity of the Topoisomerase II inhibitor etoposide was also potentiated.

Figures
Products